Results 31 to 40 of about 5,115,827 (299)

Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema

open access: yesRespiratory Research, 2021
Background Alpha-1 antitrypsin (AAT) is a major serine protease inhibitor. AAT deficiency (AATD) is a genetic disorder characterized by early-onset severe emphysema.
Katsuyuki Takeda   +4 more
doaj   +1 more source

The Different Colors of mAbs in Solution

open access: yesAntibodies, 2021
The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A
Alexandre Ambrogelly
doaj   +1 more source

Arabinosylation of recombinant human immunoglobulin-based protein therapeutics [PDF]

open access: yesmAbs, 2017
Protein glycosylation is arguably the paramount post-translational modification on recombinant glycoproteins, and highly cited in the literature for affecting the physiochemical properties and the efficacy of recombinant glycoprotein therapeutics. Glycosylation of human immunoglobulins follows a reasonably well-understood metabolic pathway, which gives
Hossler, Patrick   +13 more
openaire   +2 more sources

Recombinant human preproinsulin expression, purification and reaction with insulin autoantibodies in sera from patients with insulin-dependent diabetes mellitus [PDF]

open access: yes, 1993
A novel prokaryotic expression vector pGEX-6T was designed for high-level expression of recombinant fusion protein with a histidine-hexapeptide and glutathione-S-transferase at its N-terminus and the recombinant human preproinsulin at its C-terminus ...
Seißler, Jochen   +4 more
core   +1 more source

A Humoral Immune Response Alters the Distribution of Enzyme Replacement Therapy in Murine Mucopolysaccharidosis Type I

open access: yesMolecular Therapy: Methods & Clinical Development, 2018
Antibodies against recombinant proteins can significantly reduce their effectiveness in unanticipated ways. We evaluated the humoral response of mice with the lysosomal storage disease mucopolysaccharidosis type I treated with weekly intravenous ...
Steven Q. Le   +11 more
doaj   +1 more source

Recombinant factorVIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A [PDF]

open access: yes, 2015
This work was supported by funding from Biogen, including funding for the editorial and writing support in the the development of this ...
Barnes, C   +11 more
core   +1 more source

Construction of the Recombinant Lentiviral Vector Containing Human GH1 Gene and Its Expression in HEK293T Cells [PDF]

open access: yesJournal of Cell and Molecular Research, 2016
Human growth hormone (hGH) is a protein with multiple roles in a range of biological functions such as protein, carbohydrates and lipid metabolisms as well as immunity, tissue development and overall growth.
Zahra Roudbari   +4 more
doaj   +1 more source

GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli [PDF]

open access: yesGlycobiology, 2006
Covalent attachment of polyethylene glycol, PEGylation, has been shown to prolong the half-life and enhance the pharmacodynamics of therapeutic proteins. Current methods for PEGylation, which rely on chemical conjugation through reactive groups on amino acids, often generate isoforms in which PEG is attached at sites that interfere with bioactivity ...
DeFrees, S.   +12 more
openaire   +2 more sources

Heterologous expression of a truncated form of human recombinant vascular endothelial growth factor-A and its biological activity in wound healing [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2017
Objective(s): Vascular endothelial growth factor (VEGF) is one of the most effective proteins in angiogenesis, mesenchymal stem cells (MSCs) differentiation and wound healing.
Mohsen Khaki   +6 more
doaj   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

open access: yesFEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy